Advisors Asset Management Inc. purchased a new position in Amdocs Limited (NASDAQ:DOX - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 707,098 shares of the technology company's stock, valued at approximately $40,432,000. Advisors Asset Management Inc. owned approximately 0.66% of Amdocs as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Dimensional Fund Advisors LP grew its stake in shares of Amdocs by 19.7% in the first quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company's stock worth $226,045,000 after acquiring an additional 571,036 shares during the last quarter. Pzena Investment Management LLC boosted its stake in Amdocs by 3.4% in the 3rd quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company's stock worth $826,532,000 after purchasing an additional 469,581 shares in the last quarter. Bank of America Corp DE boosted its stake in Amdocs by 29.1% in the 1st quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company's stock worth $82,375,000 after purchasing an additional 284,435 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Amdocs by 429.6% in the 1st quarter. Renaissance Technologies LLC now owns 291,800 shares of the technology company's stock worth $19,043,000 after purchasing an additional 236,700 shares in the last quarter. Finally, Tidal Investments LLC grew its position in Amdocs by 152.3% during the 2nd quarter. Tidal Investments LLC now owns 272,345 shares of the technology company's stock valued at $13,764,000 after purchasing an additional 164,415 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the stock. Oppenheimer lowered shares of Amdocs from an "outperform" rating to a "market perform" rating in a research note on Wednesday, November 4th. Wall Street Zen downgraded shares of Amdocs from a "buy" rating to a "hold" rating in a research note on Saturday, November 7th. Zacks Research cut shares of Amdocs from a "hold" rating to a "strong sell" rating in a report on Monday, November 9th. Weiss Ratings upgraded shares of Amdocs from a "sell (d+)" rating to a "hold (c-)" rating in a report on Friday, October 23rd. Finally, Stifel Nicolaus reduced their price target on shares of Amdocs from $71.00 to $46.00 and set a "buy" rating for the company in a research report on Wednesday, November 4th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Amdocs has an average rating of "Hold" and a consensus price target of $69.00.
View Our Latest Stock Report on DOX
Insider Buying and Selling
In related news, Director Eliahu Meir Gelman bought 2,500 shares of the business's stock in a transaction on Monday, November 9th. The stock was acquired at an average price of $41.72 per share, with a total value of $104,300.00. Following the transaction, the director owned 353,446 shares in the company, valued at approximately $14,745,767.12. This trade represents a 0.71% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Shimie Hortig sold 7,255 shares of the business's stock in a transaction on Sunday, November 15th. The shares were sold at an average price of $43.34, for a total transaction of $314,431.70. Following the sale, the insider owned 178,416 shares of the company's stock, valued at approximately $7,732,549.44. This represents a 3.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have bought 8,331 shares of company stock valued at $354,505 and have sold 21,894 shares valued at $940,113. Company insiders own 15.40% of the company's stock.
Amdocs Trading Down 4.2%
Amdocs stock opened at $40.50 on Friday. Amdocs Limited has a one year low of $39.96 and a one year high of $84.95. The business's fifty day moving average is $56.06 and its 200 day moving average is $60.20. The stock has a market capitalization of $4.37 billion, a PE ratio of 8.67, a price-to-earnings-growth ratio of 1.38 and a beta of 0.42. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.94 and a quick ratio of 0.94.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, hitting analysts' consensus estimates of $1.98. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The business had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.19 billion. During the same quarter in the previous year, the firm earned $1.83 EPS. Amdocs's revenue was up 3.8% on a year-over-year basis. On average, sell-side analysts predict that Amdocs Limited will post 5.82 EPS for the current year.
Amdocs Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be given a dividend of $0.5690 per share. The ex-dividend date is Thursday, December 31st. This represents a $2.28 dividend on an annualized basis and a yield of 5.6%. Amdocs's dividend payout ratio is 48.82%.
About Amdocs
(
Free Report)
Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.
Further Reading
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.